Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024
Compare Balance Sheet Results of Bio Medica Lab
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.18
13.00
-3.82
-29.38%
Share Warrants & Outstandings
Total Reserve
5.55
-4.47
10.02
224.16%
Shareholder's Funds
14.73
8.53
6.20
72.68%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
6.76
0.00
6.76
0.00%
Secured Loans
6.76
0.00
6.76
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.22
0.00
-0.22
0.00%
Other Long Term Liabilities
0.63
0.00
0.63
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
7.17
0.00
7.17
0.00%
Current Liabilities
Trade Payables
4.28
0.04
4.24
10,600.00%
Other Current Liabilities
4.47
0.27
4.20
1,555.56%
Short Term Borrowings
8.25
0.00
8.25
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
16.99
0.30
16.69
5,563.33%
Total Liabilities
38.90
8.84
30.06
340.05%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
11.31
0.00
11.31
0.00%
Less: Accumulated Depreciation
3.85
0.00
3.85
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.46
0.00
7.46
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.21
0.00
0.21
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.13
0.00
0.13
0.00%
Total Non-Current Assets
7.81
0.00
7.81
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
18.14
0.00
18.14
0.00%
Sundry Debtors
4.10
0.00
4.10
0.00%
Cash and Bank
0.01
0.01
0.00
0.00%
Other Current Assets
1.28
5.16
-3.88
-75.19%
Short Term Loans and Advances
7.57
3.67
3.90
106.27%
Total Current Assets
31.09
8.84
22.25
251.70%
Net Current Assets (Including Current Investments)
14.10
8.53
5.57
65.30%
Total Current Assets Excluding Current Investments
31.09
8.84
22.25
251.70%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
38.90
8.84
30.06
340.05%
Contingent Liabilities
0.05
0.00
0.05
0.00%
Total Debt
15.01
0.00
15.01
0.00%
Book Value per share (adjusted)
16.05
6.56
9.49
144.66%
Annual - Borrowings
Borrowings 15.01 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 43.09% vs 9.16% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.63 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 133.33% vs 0.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 7.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.55% vs 5.05% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 31.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 194.69% vs 15.93% in Mar 2024






